Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

AtriCure Q2 Adj. EPS $(0.02) Beats $(0.17) Estimate, Sales $136.139M Beat $130.171M Estimate

Author: Benzinga Newsdesk | July 29, 2025 04:04pm
AtriCure (NASDAQ:ATRC) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.17) by 88.1 percent. This is a 88.24 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $136.139 million which beat the analyst consensus estimate of $130.171 million by 4.58 percent. This is a 17.09 percent increase over sales of $116.269 million the same period last year.

Posted In: ATRC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist